Specialized Health Services Stock Performance Review -- Acadia Healthcare, DaVita, HealthSouth, and MEDNAX - iCrowdNewswire

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Oct 12, 2017 4:30 PM ET

Specialized Health Services Stock Performance Review — Acadia Healthcare, DaVita, HealthSouth, and MEDNAX

Disclosure NewswireTM

iCrowdNewswire - Oct 12, 2017



If you want a Stock Review on ACHC, DVA, HLS, or MD then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Research coverage has been initiated by DailyStockTracker.com on Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), HealthSouth Corp. (NYSE: HLS), and MEDNAX Inc. (NYSE:MD). Companies in the Specialized Health Services category produce and distribute varying paper products to customers and businesses of all shapes and sizes. On average, the dividend yields of these firms tend to be slightly above the market average. These free stocks reports are currently available on DailyStockTracker.com. Simply sign up for your complimentary member access at:


Acadia Healthcare 

Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.’s stock finished Wednesday’s session 1.54% higher at $43.62. A total volume of 1.05 million shares was traded, which was above their three months average volume of 978,890 shares. The Company’s shares have advanced 31.78% since the start of this year. The stock is trading below its 200-day moving average by 1.61%. Moreover, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, have a Relative Strength Index (RSI) of 31.20. Your complete research report on ACHC can be retrieved for free at:



Shares in Denver, Colorado headquartered DaVita Inc. rose 0.44%, ending yesterday’s session at $54.56. A total volume of 4.32 million shares was traded, which was above their three months average volume of 1.72 million shares. The stock is trading 6.22% below its 50-day moving average. Moreover, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI of 36.04.  

On October 09th, 2017, research firm JP Morgan downgraded the Company’s stock rating from ‘Neutral’ to ‘Underweight’.

On October 10th, 2017, DaVita Kidney Care, a division of DaVita, announced that DaVita VillageHealth received a three-year recertification award from the National Committee for Quality Assurance (NCQA) under the Disease Management Certification. The full recertification denotes that as a disease management program, DaVita VillageHealth has passed a voluntary, intense, three-year review process where the NCQA examines member and practitioner services, coordination of care, program operations, evidence-based guidelines, and measurement and quality improvement.  A free report on DVA is just a click away at:



On Wednesday, Birmingham, Alabama headquartered HealthSouth Corp.’s stock climbed 0.93%, to close the day at $45.71. A total volume of 488,774 shares was traded. The Company’s shares have advanced 0.93% in the last one month and 10.84% on an YTD basis. The stock is trading 2.49% and 3.76% above its 50-day and 200-day moving averages, respectively. Additionally, shares of HealthSouth, which provides facility-based and home-based post-acute healthcare services in the US, have an RSI of 54.04.  

On September 28th, 2017, HealthSouth announced that it will report results for its Q2 ended September 30th, 2017, after the market closes on October 26th, 2017. The Company will also host an investor conference call at 9:00 a.m. ET on October 27th, 2017, to discuss its results. Sign up for your complimentary research report on HLS at:



Shares in Sunrise, Florida headquartered MEDNAX Inc. ended the day 0.60% higher at $43.29. A total volume of 1.59 million shares was traded, which was above their three months average volume of 1.20 million shares. The stock has gained 0.12% in the last one month. The Company’s shares are trading above their 50-day moving average by 0.19%. Furthermore, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 51.15.  

On September 18th, 2017, research firm KeyBanc Capital Markets upgraded the Company’s stock rating from ‘Sector Weight’ to ‘Overweight’.

On September 28th, 2017, MEDNAX announced the acquisition of Jefferson Radiology, PC and Jefferson Imaging Associates, LLC based in Hartford, Connecticut. This partnership meaningfully expands MEDNAX’s radiology services and further establishes it as the partner of choice for leading radiology practices and radiology physician services by combining physician excellence with world-class technological capabilities. Register for free on DailyStockTracker.com and download the latest research report on MD at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


For any questions, inquiries, or comments reach out to us directly. If youre a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

Contact Information:

Email: [email protected]
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

View Related News >